Clinical implications of fracture-associated vascular damage in extremity and pelvic trauma

Table 1 Laboratory results and pre-clinical fluid administratio

	Hemoglobin (mg/dl)	Quick (%)	PTT (s)	Fibrinogen (g/l)	Lactate (mmol/l)	Myoglobin (μg/l)	Creatine kinase (U/l)	Crystallines (ml)	Colloids (ml)	Total volume (ml)
Vascular injury group	9.95 ± 2.6	59.2 ± 21.6	41.9 ± 25.2	1.7 ± 0.9	2.1 ± 1.2	1356 ± 1441	393 ± 316	1000 ± 741	500 ± 0	1500 ± 1112
Fracture only group	11.67 ± 2.6	78.0 ± 19.3	35.3 ± 20.7	2.2 ± 0.6	1.8 ± 0.9	855 ± 856	372 ± 337	1000 ± 0	500 ± 0	1000 ± 741
P	0.0004	0.0002	0.002	0.003	0.24	0.24	0.77	0.09	0.64	0.03

The table shows the mean ± standard deviation (SD) or median ± median absolute deviation (MAD) where appropriate (cristalloides; colloides) for each parameter and the P-value for comparison between vascular and control trauma population. Significant P-values are shown in bold. (normal ranges: hemoglobin: 11.5-16 g/dL; prothrombin time according to Quick: 70–120%; activated partial thromboplastin time, PTT: 25–36 s; fibrinogen: 1.6–4.0 g/L; lactate: < 0.5 mmol/L; Myoglobin: < 55 μg/L; creatin kinase: < 170 U/L)

ISSN: 1471-2474